Sanofi seeks more funding on Genzyme bid: report

PHILADELPHIA (Reuters) – French drugmaker Sanofi-Aventis is seeking to line up more funding to potentially raise its $18.5 billion bid for Genzyme Corp, The Wall Street Journal reported on Sunday.

Leave a Reply